Cabaletta Bio reported earnings of -$ 0.28 per CABA share on Nov 5, 2026, falling short of analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | -$ 0.32 |
| Earnings Per Share (Surprise) | -$ 0.28 (+$ 0.03736) |
| Last Year's EPS | -$ 0.57 |
| EPS YoY Change |
Out of the last 35 earnings reporting periods, Cabaletta Bio beat analysts’ expectations 18 times and fell short of expectations 10 time(s). Cabaletta Bio reported earnings per share of -$ 0.28 in the last report surpassing an estimated EPS of -$ 0.32 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.32 | -$ 0.28 | -$ 0.44 | |
| Aug 13, 2026 | -$ 0.37 | -$ 0.34 | -$ 0.73 | |
| May 14, 2026 | -$ 0.41 | -$ 0.39 | -$ 0.71 | |
| Mar 23, 2026 | -$ 0.45 | -$ 0.40 | -$ 0.65 | |
| Nov 10, 2025 | -$ 0.49 | -$ 0.44 | -$ 0.62 | |
| Aug 7, 2025 | -$ 0.71 | -$ 0.73 | -$ 0.56 | |
| May 15, 2025 | -$ 0.67 | -$ 0.71 | -$ 0.51 | |
| Mar 31, 2025 | -$ 0.65 | -$ 0.65 | -$ 0.46 | |
| Nov 14, 2024 | -$ 0.59 | -$ 0.62 | -$ 0.37 | |
| Aug 8, 2024 | -$ 0.55 | -$ 0.56 | -$ 0.37 | |
| May 15, 2024 | -$ 0.48 | -$ 0.51 | -$ 0.45 | |
| Mar 21, 2024 | -$ 0.39 | -$ 0.46 | -$ 0.52 | |
| Nov 9, 2023 | -$ 0.39 | -$ 0.37 | -$ 0.39 | |
| Aug 10, 2023 | -$ 0.47 | -$ 0.37 | -$ 0.45 | |
| May 11, 2023 | -$ 0.48 | -$ 0.45 | -$ 0.45 | |
| Mar 16, 2023 | -$ 0.47 | -$ 0.52 | -$ 0.49 | |
| Nov 10, 2022 | -$ 0.49 | -$ 0.39 | -$ 0.45 | |
| Aug 11, 2022 | -$ 0.52 | -$ 0.45 | -$ 0.45 | |
| May 12, 2022 | -$ 0.64 | -$ 0.45 | -$ 0.41 | |
| Mar 17, 2022 | -$ 0.68 | -$ 0.49 | -$ 0.40 |
Cabaletta Bio’s stock was trading at $ 1.42 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, CABA’s price decreased to $ 1.30 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.28 | $ 1.42 | $ 1.30 | |
| Aug 13, 2026 | -$ 0.34 | $ 2.85 | $ 2.75 | |
| May 14, 2026 | -$ 0.39 | $ 3.59 | $ 3.31 | |
| Mar 23, 2026 | -$ 0.40 | $ 2.94 | $ 2.67 | |
| Nov 10, 2025 | -$ 0.44 | $ 2.55 | $ 2.47 | |
| Aug 7, 2025 | -$ 0.73 | $ 1.45 | $ 1.36 | |
| May 15, 2025 | -$ 0.71 | $ 1.30 | $ 2.03 | |
| Mar 31, 2025 | -$ 0.65 | $ 1.55 | $ 1.17 | |
| Nov 14, 2024 | -$ 0.62 | $ 4.01 | $ 3.03 | |
| Aug 8, 2024 | -$ 0.56 | $ 6.11 | $ 4.16 | |
| May 15, 2024 | -$ 0.51 | $ 11.23 | $ 12.62 | |
| Mar 21, 2024 | -$ 0.46 | $ 18.12 | $ 17.35 | |
| Nov 9, 2023 | -$ 0.37 | $ 17.19 | $ 17.88 | |
| Aug 10, 2023 | -$ 0.37 | $ 12.38 | $ 13.62 | |
| May 11, 2023 | -$ 0.45 | $ 12.30 | $ 12.50 | |
| Mar 16, 2023 | -$ 0.52 | $ 7.41 | $ 8.10 | |
| Nov 10, 2022 | -$ 0.39 | $ 1.94 | $ 2.38 | |
| Aug 11, 2022 | -$ 0.45 | $ 1.28 | $ 1.53 | |
| May 12, 2022 | -$ 0.45 | $ 1.23 | $ 1.49 | |
| Mar 17, 2022 | -$ 0.49 | $ 1.71 | $ 1.96 |
Cabaletta Bio released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Cabaletta Bio beat analysts’ expectations during the last earnings period by
